{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:52:50Z","timestamp":1772034770478,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04788-5","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:34:05Z","timestamp":1757608445000},"page":"1015-1021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in mortality of renal failure in adult multiple myeloma patients: a CDC data analysis (1999\u20132020)"],"prefix":"10.1007","volume":"58","author":[{"given":"Hafsa","family":"Shahid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Sial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"issue":"13","key":"4788_CR1","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"International Myeloma Working Group","year":"2016","unstructured":"International Myeloma Working Group (2016) Renal impairment in multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 34(13):1544\u20131557. https:\/\/doi.org\/10.1200\/JCO.2015.65.0044","journal-title":"J Clin Oncol"},{"issue":"9","key":"4788_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/leu.2008.131","volume":"22","author":"MA Dimopoulos","year":"2008","unstructured":"Dimopoulos MA, Kastritis E, Rosinol L, Blad\u00e9 J, Ludwig H (2008) Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia 22(9):1485\u20131493. https:\/\/doi.org\/10.1038\/leu.2008.131","journal-title":"Leukemia"},{"key":"4788_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841226","volume":"12","author":"A Ravinia","year":"2022","unstructured":"Ravinia A, D\u2019Agostino M, Martino E, Pantani L, Ruggiero C, Musto P (2022) The impact of renal impairment on survival outcomes in newly diagnosed multiple myeloma patients. Front Oncol 12:841226. https:\/\/doi.org\/10.3389\/fonc.2022.841226","journal-title":"Front Oncol"},{"issue":"2","key":"4788_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41408-019-0176-z","volume":"9","author":"S Ailawadhi","year":"2019","unstructured":"Ailawadhi S, Jacobus S, Sexton R et al (2019) Racial disparities in treatment and outcomes among patients with multiple myeloma: a SWOG study. Blood Cancer J 9(2):15. https:\/\/doi.org\/10.1038\/s41408-019-0176-z","journal-title":"Blood Cancer J"},{"issue":"16","key":"4788_CR5","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1182\/blood-2017-05-782920","volume":"130","author":"LJ Costa","year":"2017","unstructured":"Costa LJ, Brill IK, Omel J, Godby K, Kumar SK, Brown EE (2017) Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood 130(16):2128\u20132138. https:\/\/doi.org\/10.1182\/blood-2017-05-782920","journal-title":"Blood"},{"issue":"12","key":"4788_CR6","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1182\/blood-2010-03-273656","volume":"116","author":"H Ludwig","year":"2010","unstructured":"Ludwig H, Adam Z, Hajek R et al (2010) Bortezomib plus dexamethasone versus dexamethasone alone in relapsed or refractory multiple myeloma: a multicenter, randomized, open-label, phase 3 study. Blood 116(12):2000\u20132006. https:\/\/doi.org\/10.1182\/blood-2010-03-273656","journal-title":"Blood"},{"issue":"12","key":"4788_CR7","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1681\/ASN.2016121326","volume":"28","author":"F Bridoux","year":"2017","unstructured":"Bridoux F, Carron PL, Pegourie B et al (2017) Effect of lenalidomide plus dexamethasone on renal response and overall survival in patients with multiple myeloma and renal impairment. J Am Soc Nephrol 28(12):3681\u20133691. https:\/\/doi.org\/10.1681\/ASN.2016121326","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"4788_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.168","volume":"47","author":"CA Hutchison","year":"2012","unstructured":"Hutchison CA, Cockwell P, Stringer S et al (2012) Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. Bone Marrow Transplant 47(7):865871. https:\/\/doi.org\/10.1038\/bmt.2011.168","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"4788_CR9","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1093\/ndt\/gfs209","volume":"27","author":"N Leung","year":"2012","unstructured":"Leung N, Nasr SH, Sethi S (2012) How I treat amyloidosis: the importance of accurate diagnosis and risk stratification. Nephrol Dial Transplant 27(10):3823\u20133828. https:\/\/doi.org\/10.1093\/ndt\/gfs209","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"4788_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","volume":"48","author":"JA Katzmann","year":"2002","unstructured":"Katzmann JA, Clark RJ, Abraham RS et al (2002) Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 48(9):1437\u20131442. https:\/\/doi.org\/10.1093\/clinchem\/48.9.1437","journal-title":"Clin Chem"},{"issue":"3","key":"4788_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","volume":"19","author":"N Raje","year":"2018","unstructured":"Raje N, Terpos E, Willenbacher W et al (2018) Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, multicentre, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol 19(3):370\u2013381. https:\/\/doi.org\/10.1016\/S1470-2045(18)30072-X","journal-title":"Lancet Oncol"},{"issue":"9","key":"4788_CR12","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1080\/10428194.2020.1758216","volume":"61","author":"JN Saultz","year":"2020","unstructured":"Saultz JN, Garzon R (2020) Socioeconomic status and outcome in patients with multiple myeloma. Leuk Lymphoma 61(9):2145\u20132153. https:\/\/doi.org\/10.1080\/10428194.2020.1758216","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"4788_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jamaoncol.2018.6731","volume":"5","author":"NR Fillmore","year":"2019","unstructured":"Fillmore NR, Yellapragada SV, Ifthikhar S et al (2019) Disparities in access and outcomes for Black patients with multiple myeloma: a comprehensive review. JAMA Oncol 5(3):385\u2013393. https:\/\/doi.org\/10.1001\/jamaoncol.2018.6731","journal-title":"JAMA Oncol"},{"key":"4788_CR14","unstructured":"Centers for Disease Control and Prevention (CDC). Chronic Kidney Disease (CKD) Initiative. Updated March 2024. Accessed May 2025. https:\/\/www.cdc.gov\/kidneydisease\/index.html"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04788-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04788-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04788-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:30:54Z","timestamp":1772029854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04788-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4788"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04788-5","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval is not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors affirm that the submitted manuscript is original and has not been published elsewhere in the same or substantially similar form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Dual publication statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"We, the authors, consent to the publication of our manuscript titled \u201cTrends in Mortality of Renal Failure in Adult Multiple Myeloma Patients: A CDC Data Analysis (1999\u20132020)\u201d and confirm that all authors have approved the final version and agree to its submission and publication in International Urology and Nephrology Journal.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}